FDA found Yara Elena De La Garza Perez Nieto's DAESI Hand Sanitizer contained methanol instead of labeled ethanol and was adulterated and misbranded.
What happened
FDA laboratory testing of batches of DAESI Hand Sanitizer, labeled as manufactured at the firm's facility, was done after the product was detained and refused admission at the U.S. border. The tests found methanol, a toxic chemical not acceptable in hand sanitizers, less ethanol than the labeled 70%, and in one batch undeclared isopropanol. FDA held a July 10, 2020 teleconference with the firm and its U.S. agent and posted public notice of the methanol contamination.
What FDA found
The hand sanitizer's labeled active ingredient ethanol was substituted wholly or partly with methanol, a dangerous chemical.
FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)The substitution showed the firm's quality assurance was not working under current good manufacturing practice (CGMP) requirements.
FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)The hand sanitizer is an unapproved new drug because it is not generally recognized as safe and effective and lacks FDA approval or coverage under section 505G.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The product is misbranded because it is dangerous to health when used as labeled due to methanol.
FD&C Act section 502(j), 21 U.S.C. 352(j)The labeling is false or misleading because it says 70% ethanol but contains less ethanol and undeclared isopropanol and methanol.
FD&C Act section 502(a), 21 U.S.C. 352(a)The label fails to list methanol and isopropanol as ingredients.
FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A)
What FDA wants
Within 15 working days, respond in writing with a detailed investigation of the methanol substitution, lists of raw materials and suppliers, all U.S.-shipped batches with reconciliation, complete batch records, and a plan to test each component lot, including every ethanol lot for methanol by USP method. FDA also recommends a qualified CGMP consultant and a regulatory meeting if the firm wants to make U.S. drugs in future.
Who should pay attention
- brands and retailers that buy imported hand sanitizer
- distributors and importers of Mexican-made OTC drugs
- drug quality teams that rely on ethanol supplier certificates
This is a summary. Read the original letter on fda.gov.